Baird Financial Group’s BeOne Medicines Ltd. American Depositary Shares ONC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $82.9M | Buy |
342,442
+68,046
| +25% | +$16.5M | 0.15% | 117 |
|
2025
Q1 | $74.7M | Sell |
274,396
-21,166
| -7% | -$5.76M | 0.14% | 124 |
|
2024
Q4 | $54.6M | Buy |
295,562
+8,448
| +3% | +$1.56M | 0.1% | 177 |
|
2024
Q3 | $64.5M | Buy |
287,114
+25,004
| +10% | +$5.61M | 0.13% | 163 |
|
2024
Q2 | $37.4M | Buy |
262,110
+11,243
| +4% | +$1.6M | 0.08% | 235 |
|
2024
Q1 | $39.2M | Buy |
250,867
+85,934
| +52% | +$13.4M | 0.08% | 227 |
|
2023
Q4 | $29.7M | Buy |
164,933
+34,481
| +26% | +$6.22M | 0.07% | 251 |
|
2023
Q3 | $23.5M | Buy |
130,452
+15,264
| +13% | +$2.75M | 0.06% | 256 |
|
2023
Q2 | $20.5M | Buy |
115,188
+8,982
| +8% | +$1.6M | 0.05% | 294 |
|
2023
Q1 | $22.9M | Buy |
106,206
+3,006
| +3% | +$648K | 0.06% | 281 |
|
2022
Q4 | $22.7M | Sell |
103,200
-376
| -0.4% | -$82.7K | 0.06% | 281 |
|
2022
Q3 | $14M | Buy |
103,576
+5,804
| +6% | +$782K | 0.04% | 348 |
|
2022
Q2 | $15.8M | Buy |
97,772
+4,170
| +4% | +$675K | 0.04% | 345 |
|
2022
Q1 | $17.7M | Buy |
93,602
+8,967
| +11% | +$1.69M | 0.04% | 333 |
|
2021
Q4 | $22.9M | Buy |
84,635
+643
| +0.8% | +$174K | 0.05% | 295 |
|
2021
Q3 | $30.5M | Buy |
83,992
+4,123
| +5% | +$1.5M | 0.08% | 238 |
|
2021
Q2 | $27.4M | Buy |
79,869
+6,465
| +9% | +$2.22M | 0.07% | 252 |
|
2021
Q1 | $25.6M | Sell |
73,404
-8,589
| -10% | -$2.99M | 0.07% | 249 |
|
2020
Q4 | $21.2M | Buy |
81,993
+2,040
| +3% | +$527K | 0.06% | 274 |
|
2020
Q3 | $22.9M | Buy |
79,953
+2,336
| +3% | +$669K | 0.08% | 243 |
|
2020
Q2 | $15K | Buy |
77,617
+2,982
| +4% | +$576 | ﹤0.01% | 1503 |
|
2020
Q1 | $9.19M | Buy |
+74,635
| New | +$9.19M | 0.04% | 338 |
|